[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text]

Similar documents
PAIN MANAGEMENT Patient established on oral morphine or opioid naive.

Care of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure.

Renal Prescribing at End of Life Guidance for Anticipatory prescribing for patients in renal failure (egfr<30) at the end of life

PAIN MANAGEMENT Person established taking oral morphine or opioid naive.

Symptom Management Guidelines for End of Life Care

PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT

Care of the Dying Management in Severe Renal Failure

Care of the Dying Management in Severe Renal Failure

Supporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety

Algorithms for Symptom Management. In End of Life Care

Anticipatory Medications for End of Life Patients. Doses must be proportional to the current analgesic medication YES NO YES NO

MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life

ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL IMPAIRMENT

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.

Syringe driver in Palliative Care

Renal Palliative Care Last Days of Life

PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE

SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRESCRIPTION & ADMINISTRATION RECORD (SPAR) Name: Address: Postcode: Date of Birth: NHS Number:

End of life prescribing guidance

ALLERGIES/ SENSITIVITIES This section must be completed before prescribing/administering any drug

Supportive Care. End of Life Phase

PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth)

Care in the Last Days of Life

Diamorphine 4 hour. alfentanil (500microgram/mL) Calculated by dividing 24 hour oral morphine dose by 30

GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT (estimated glomerular filtration rate<30)

Essential Syringe Driver Training for T 34. Elaine Bird St Luke s Hospice

SYRINGE DRIVER MEDICATIONS

End of Life Care. Dr Anne Garry Consultant in Palliative Medicine

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

Palliative Care Impact Survey

Syringe Drivers. Back to top

End Stage Liver Disease Regional Audit Casenote Survey

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS

Drug Prescription and Administration Record

SYMPTOM CONTROL IN THE LAST DAYS OF LIFE. Bradford, Airedale, Wharfedale & Craven

Using syringe pumps in palliative care

Anticipatory prescribing and end of life considerations. Dr Stephanie Lippett

Palliative care for heart failure patients. Susan Addie

Care of dying adults in the last days of life. Improving care at the very end of life.

MND Just in Case kit Information for GPs

Drug Administration Document for Babies, Children and Young People Requiring Symptom Management

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL

Coversheet for Network Site Specific Group Agreed Documentation

INTEGRATED CARE PATHWAY (ICP) FOR THE DYING ADULT

Palliative care for patients with brain cancer

Implementing the recommendation on medication management and symptom control

ADULT SYRINGE DRIVER PROTOCOL (T34)

Palliative Care Out-of-hours. A resource pack for West Dorset. Contents:

Regional Breathlessness Audit - Case Note Survey. 1. Introduction. Regional Breathlessness Audit - Case Note Survey. 2.

PCA PRESCRIPTION is valid for a maximum of 4 days unless ceased earlier. Date: BINDING MARGIN - NO WRITING BINDING MARGIN - NO WRITING

BREATHLESSNESS MANAGEMENT

This survey aims to look at individual practice and can be completed by any healthcare professional.

Conservative Management of Uraemia

Doncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary

Clatterbridge Centre for Oncology

Adult Palliative and Supportive Care: Ambulatory Syringe Pump Policy including Symptom Management Guidelines

Isle of Wight Syringe Driver Compatibility Guidelines

Evaluation of McKinley T34 Syringe Pumps

The last days of life in hospital and at home

Berkshire Adult Palliative Care Guidelines - End of Life Care GL110

Syringe Pumps: Guidance for the use with babies, children and young people in the community setting within Worcestershire

SAMPLE. This direction was authorised on 4/5/2007. The direction will be reviewed by 4/5/2009

Policy/Standard Operating Procedure/ Clinical Guideline. ELHT/CP22 Version 5.1. ELHT/CP22 Version 4.1

A Brief Guide to Symptom Management and End of Life Care for Children During Pandemic Influenza

Regional Renal Training

McKinley T34 Syringe Pump Policy and Procedure

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care

Palliative Care. Anticipatory Prescribing Guidelines & June Gippsland Region Palliative Care Consortium Clinical Practice Group

What else is new (other symptoms) DR ANDREW DAVIES

POLICY / PROCEDURE FOR THE USE OF THE McKinley T34 SYRINGE DRIVER

Analgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti-


Guidance for the Use of Subcutaneous Furosemide by Continuous Infusion for Heart Failure in Community Settings

Managing Symptoms in End of Life Care

Appendix: Sample prescription form. The following sample prescription form gives examples of sections found in most hospital prescription forms.

BACKGROUND Measuring renal function :

1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER

survey Parenteral anti-epileptics What is your experience? May July 2015

Report to: Public Board of Directors Agenda item: 11 Date of Meeting: 25 July Gosport Hospital Report & RUH Assurance

PAEDIATRIC DOSAGE GUIDELINES For management of post-operative acute pain

Alternative Routes of Drug Administration (analgesia) Dr Andrew Dickman Consultant Pharmacist

Target audience: The target audience for this guidance are: GPs Care home managers and nurses, District nurses, and Specialist Palliative Care teams.

Approach to symptom control near the end-of-life

Administration of Drugs via the CME Medical T34 Syringe Driver Standard Operating Procedure

Ventilation/End of Life Neuromuscular Disorders. Dr Emma Husbands Consultant Palliative Medicine

Planning for the future; A guide to symptom control at end of life in advanced dementia

SYRINGE DRIVERS: GUIDANCE FOR THE USE IN THE COMMUNITY and COMMUNITY HOSPITAL SETTING WITHIN WORCESTERSHIRE

Waterloo Wellington (WW) Symptom Management Guideline for the End of Life (EOL) Medication Order Set for Long Term Care (LTC)

We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients.

Use of the Graseby MS26 Syringe Driver For Palliative Care Within West Lothian

SHARED CARE GUIDELINE For

Palliative Care and the Critical Role of the Pharmacist. Arti Thakerar Education/ Palliative Care Peter MacCallum Cancer Centre

Palliative Prescribing - Pain

Community Pharmacy Enhanced Service. Just In Case 4 Core Drugs supply. Stock Holding of Palliative Care Medicines

Managing Respiratory Symptoms - Breathlessness, Cough and Secretions. Dr Laura Healy. Palliative Medicine Registrar, Beaumont Hospital.

** Medication exercises ** NICU Phase II

In our patients the cause of seizures can be broadly divided into structural and systemic causes.

1 (ix) Pain control. What responsibilities do you assume when you prescribe analgesia?

Transcription:

[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text] Patients with egfr greater than 30mL/min Patients with egfr less than 30mL/min Symptom Drug Dose Symptom Drug Dose PAIN Opioid naïve patient PAIN Patient already on strong opioid AGITATION NAUSEA &/OR VOMITING (If in bowel obstruction contact Specialist Palliative Care) CHEST SECRETIONS BREATHLESSNESS Morphine Sulfate for injection 2.5mg 5 mg Subcutaneously (S/C) PRN up to hourly. Up to maximum 6 doses in 24 Contact Specialist Palliative Care Team for advice Midazolam Levomepromazine Glycopyrronium Bromide Morphine Sulfate for injection Midazolam 2.5mg 5mg Subcutaneously (S/C) PRN up to hourly Up to maximum 6 doses in 24 6.25mg Subcutaneously (S/C) PRN Up to maximum 4 doses in 24 200micrograms subcutaneously (S/C) PRN Up to maximum 4 doses in 24 2.5mg 5mg Subcutaneously (S/C) PRN up to hourly Up to maximum 6 doses in 24 2.5mg 5 mg Subcutaneously (S/C PRN up to hourly Up to maximum 6 doses in 24 PAIN Opioid naïve patient PAIN Patient already on strong opioid AGITATION NAUSEA &/OR VOMITING (If in bowel obstruction contact Specialist Palliative Care Team) CHEST SECRETIONS BREATHLESSNESS Morphine Sulfate for Injection 1.25mg -2.5mg Subcutaneously (S/C) PRN 2-4 hourly Up to maximum 6 doses in 24 Contact Specialist Palliative Care Team for advice Midazolam Haloperidol (Avoid in patients with Parkinson s disease) Glycopyrronium Bromide Morphine Sulfate for Injection Midazolam 1.25mg 2.5mg Subcutaneously (S/C) PRN 2-4 hourly Up to maximum 6 doses in 24 0.5mg-1mg subcutaneously (S/C) PRN Up to maximum 3 doses in 24 200micrograms subcutaneously (S/C) PRN Up to maximum 4 doses in 24 1.25mg -2.5mg Subcutaneously (S/C) PRN 2-4 hourly Up to maximum 6 doses in 24 1.25mg 2.5mg Subcutaneously (S/C) PRN 2-4 hourly Up to maximum of 6 doses in 24 There is a 7 day Specialist Palliative Care Service from 9am 5pm in the community, and 5 days a week in the acute hospital If Specialist Palliative Medicine advice is required in, please contact: Hospital team: 01384 244238 / Community team: 01384 321 523 Weekend community team: 01384 321 600 option 1 Out of : Palliative Medicine advice via on call nurse / doctor available via Compton Care (previously known as Compton Hospice) 0300 323 0250

[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text] If a patient is requiring 3 or more repeated doses of the same drug in 24 then it would be good practice to consider a syringe driver When prescribing a syringe driver please then consider the following: 1) The starting dose of medication should reflect the total of the subcutaneous doses used in a 24 hour period and any regular medication used for symptom control including analgesia, anti-emetics etc. 2) The table below gives some guidance when starting a syringe driver, but prescribing should be considered on an individual patient basis (eg with consideration of egfr, any regular medication that the patient is already on for symptom control etc). For more information please use the West Midlands Palliative Care Physicians guidance 3) Remember to consider compatability of drugs in a syringe driver, and also check which diluent is needed. Diluent will need to be prescribed. INDICATION MEDICATION SUBCUTANEOUS STARTING DOSE OVER 24 HRS Pain Morphine Sulfate Alfentanil (First Line if egfr < 30) ½ of total dose of oral morphine/ 24 hrs or Total of subcutaneous PRN doses / 24 hrs. Please seek Specialist Palliative Care advice Nausea and Vomiting Levomepromazine Haloperidol (First line if egfr <30) 6.25mg/24 hrs (max 25mg) 1.5mg - 2.5mg/24 hrs (max 5mg) Agitation in the dying patient Midazolam 5mg/24 hrs (max 30mg) Respiratory secretions in the dying patient Glycopyrronium Bromide 0.6mg/24 hrs ( Max 1.2mg)

ADMINISTRATION OF SUBCUTANEOUS DRUGS VIA McKINLEY T34 SYRINGE PUMP AND AS REQUIRED PRN ANTICIPATORY MEDICATION GP Practice Name Any known drug allergies (sensitivities) : GP Practice Contact Details: Opioid Patch in Situ: Please Circle: YES/NO ( please specify if patch is to remain in-situ or be removed if commencing syringe driver) egfr checked: Please Circle: YES/NO Greater than 30 ml/min Less than 30 Please refer to medication guidance on reverse SECTION 1 AS REQUIRED PRN ANTICIPATORY MEDICATION Drug Dose (Range) Frequency Max 24hr Dose Inclusive of Syringe Pump Indication Name of Prescriber GMC / NMC Number Contact Number Signature Pain / Breathlessness Anxiety / Agitation Nausea / Vomiting Respiratory Tract Secretions PLEASE PRESCRIBE AS REQUIRED DRUGS FOR ALL PATIENTS Consider prescribing for: Pain, Nausea/Vomiting, Agitation, Secretions. Given by subcutaneous injection unless otherwise indicated. Please see quick reference guide for Anticipatory Prescribing on page 1-2. For specialist Palliative Care Advice call 01384 321523 (in working ) or Call 0300 323 0250 (Compton Care Out of Hours)

CONTINUOUS SUBCUTANEOUS INFUSION (SYRINGE PUMP) AUTHORISATION GP Practice and Contact Details Any Known Drug Allergies Opioid Patch Insitu? Please circle YES/NO egfr Checked? Please circle YES/NO : Drug (By continuous subcutaneous infusion) Dose Range (In words and figures) Max Dose in 24 Name GMC no. and Signature Use water for injection as diluent unless otherwise indicated. Up to 17ml (20ml syringe) 22ml (30 ml syringe) Those changing the dose administered (within the range prescribed) should follow guidelines, record the reason for change in the care plan and act within their competency

Drugs in Situ (inc dose) CME McKINLEY T34 SYRINGE PUMP SUBCUTANEOUS CHECKLIST FOR COMMUNITY USE (DD/MM/YYYY) Time ( 24 Hour Clock) Syringe Size; mls /Hour Set to correct syringe type/size Rate settings mls/hour Solution Clear? Site Satisfactory? Cannula Resited? Volume to be infused (mls) Battery % Light Flashing Keypad Locked Drug Stock List Updated Initials

Do not commence infusion if battery status is 40% or less. ARE THERE SUFFICIENT DRUGS FOR THE NEXT 48 HOURS Drug: Drug Sheet Administration Record PRN or via Syringe Driver One Drug Per Page and time Dose and Route Ampoules used New Stock Stock Balance Batch Number / Expiry Full Signature / Printed Name / Designation

ARE THERE SUFFICIENT DRUGS FOR THE NEXT 48 HOURS Drug: Drug Sheet Administration Record PRN or via Syringe Driver One Drug Per Page and time Dose and Route Ampoules used New Stock Stock Balance Batch Number / Expiry Full Signature / Printed Name / Designation

ARE THERE SUFFICIENT DRUGS FOR THE NEXT 48 HOURS Drug: Drug Sheet Administration Record PRN or via Syringe Driver One Drug Per Page and time Dose and Route Ampoules used New Stock Stock Balance Batch Number / Expiry Full Signature / Printed Name / Designation

ARE THERE SUFFICIENT DRUGS FOR THE NEXT 48 HOURS Drug: Drug Sheet Administration Record PRN or via Syringe Driver One Drug Per Page and time Dose and Route Ampoules used New Stock Stock Balance Batch Number / Expiry Full Signature / Printed Name / Designation